Latest filing published 04 Feb 2014 for INVITROGEN CORP, €293k.
No signal scores available.
This profile gathers the share dealings of Kelli Richard in Invitrogen Corp. We count 96 filings; the first trade dates from 15 May 2007 and the latest from 3 February 2014.
No open-market purchase appears, only 65 sales worth €1.4M. Outside the open market, there are 13 share grants and 16 option exercises.
Most recently, on 4 February 2014, the filings show a transaction worth €293k in Invitrogen Corp. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 90 declarations